MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Monday, June 5, 2017

1:45pm-3:15pm
The clinical phenotype of progressive supranuclear gaze palsy with predominant cerebellar ataxia (PSP-C): a case series

Z. Xu, T. Lim, W.L. Au, L. Tan (Singapore, Singapore)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Exhibit Hall C
1:45pm-3:15pm
The complex relationship between olfactory and cognitive impairment in Parkinson’s disease

J. Djordjevic, N.S. Saadat, A. Sadikot, T. White (Montreal, QC, Canada)

Parkinson's Disease: Non-Motor Symptoms  ·  Exhibit Hall C
1:45pm-3:15pm
The DBS response ratio: An individual benchmark parameter of DBS quality

L. Lange, M. Reich, R. Nickl, F. Steigerwald, C. Matthies, J. Volkmann (Wuerzburg, Germany)

Surgical Therapy: Parkinson’s Disease  ·  Exhibit Hall C
1:45pm-3:15pm
The diagnostic challenges of patients with possible multiple system atrophy

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Exhibit Hall C
1:45pm-3:15pm
The effect and mechanism of acupuncture for pain in Parkinson’s disease

S.-W. Yu, Y.-R. Wu, J.-J. Wang, C.-C. Tsai (Taoyuan, Taiwan)

Parkinson's Disease: Non-Motor Symptoms  ·  Exhibit Hall C
1:45pm-3:15pm
The effect of deep brain stimulation in a computational model of essential tremor

N. Yousif, M. Mace, N. Pavese, S. Al-Rasheed, R. Borisyuk, P. Bain, D. Nandi (Hatfield, United Kingdom)

Surgical Therapy: Other Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population

M.-C. Kuo, Y.-C. Lu, M.-L. Chen, C.-H. Tai, C.-H. Lin, R.-M. Wu (Taipei, Taiwan)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Exhibit Hall C
1:45pm-3:15pm
The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.

D. Stephenson, A. Porter, K. Romero, G. Podskalny, E. Bastings, B. Dunn, S. Goldstein, T. Mullin (Tucson, AZ, USA)

Quality Of Life/Caregiver Burden in Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

Parkinson's Disease: Non-Motor Symptoms  ·  Exhibit Hall C
1:45pm-3:15pm
The impact of intensive voice treatment on swallowing in Parkinson disease

D. McFarland, L. Ramig, B. Martin-Harris, K. Humphries, J. Logemann, K. Freeman, A. Halpern, J. Spielman (Montréal, QC, Canada)

Parkinson's Disease: Non-Motor Symptoms  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 39
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley